Chile Begins Harvest of Latin America’s Largest Legal Cannabis Crop

Various medical cannabis organizations in Chile began harvesting Latin America’s largest single crop of legal cannabis on Wednesday.

The field, which is the most expansive on the continent, lies in rural southern Chile, not far from the Andes Mountains.

The harvesting project was given the go-ahead by the Chilean government, and will cut down the buds of some 6,000 cannabis plants for transformation into various phytopharmaceuticals for the country’s 4,000 medical cannabis patients.

All of this is being done for free. The purpose of the project is to provide cannabis for use in three clinical studies, which will be run by the Chilean National Cancer Institute and two hospitals.

Ana Maria Gazmuri, president of the Daya Foundation, said that “it is an important day. We want it to be the first harvest of many more to come in Latin American countries.” The Daya Foundation promotes alternative therapy research.

The clinical studies are being funded by 20 municipalities, and will focus on the effectiveness of cannabis in treating patients suffering from cancer, refractory epilepsy and chronic pain.

Chile legalized the production and sale of hemp-derived drugs last December. Puerto Rico and Colombia have recently followed suit.

Although marijuana remains on Chile’s list of hard drugs, Chilean president Michelle Bachelet signed an order at the end of 2015 that gave the Institute of Public Health the power to authorize the production of marijuana for medicinal purposes.

End


MMJ Tax in LA Could Fund Homeless Services Plan

Los Angeles, California city officials have proposed a 15 percent tax on medical marijuana sales and cultivation in the city in order to generate funds for homeless housing and services, according to a document outlining potential means.

If approved, the plan is estimated to raise $16.7 million annually based on current medical marijuana receipts, but that number could increase significantly if recreational marijuana were approved in the state and subjected to the same rate.

It is not unheard of for a municipality to levy additional taxes on top of the exiting 6 percent tax for medical marijuana gross receipts.  In 2014, Cathedral City and Desert Hot Springs, in Riverside County, each raised their tax to 15 percent and 10 percent, respectively. Santa Cruz city and county added a 4 percent retail tax and Shasta Lake City, in Shasta County, added a 6 percent sales tax.

Taxing medical cannabis is one of nine recommendations put forth by Chief Legislative Analyst Sharon Tso and City Administrative Officer Miguel Santana in the letter to members of the Homelessness and Poverty Committee.

Other options include a fee in lieu of inclusionary zoning, housing linkage fees, a real estate document fee, a bond worth up to $1.8 billion, a documentary transfer tax, a billboard tax, raising the sales and use tax 1 percent, and a parcel tax.

“There are multiple, anticipated initiatives involving marijuana on the Nov. 2016 ballot,” the authors noted as potential disadvantages for the plan “This may lead to confusion on behalf of the voting public.”

Whichever funding option is chosen by the committee will appear on the November ballot and would need to be approved by voters.

End


Oregon Health Authority Updates Concentrate Policies for Betterment of Patients

The Oregon Health Authority (OHA), facing backlash from the state’s medical marijuana community over a recent ban on the sale and production of cannabis concentrates, displayed a more progressive understanding of the crisis now facing patients situation in new rules rolled out this week.

The OHA’s recent ban on concentrates was intended only as a temporary condition — specifically, the agency banned the sale of concentrates that were produced by an unlicensed entity, which, because there are currently no licenses available, functioned as a blanket ban on that entire aspect of the industry.

The new rules, however, make some much-needed clarifications about the legality of extracts in Oregon.

Specifically, concentrates and edibles that are currently in circulation will be allowed to stay there. Furthermore, processors who have submitted a completed application by to the OHA can begin operating on April 1 under a provisional license. The rights to a provisional license will be removed October 1, 2016, after enough producers and processors have been officially licensed.

Read the full bulletin posted by the OHA below:

ohabulletin2

End


Cannabis Product Recalls and Other Rule Changes Announced in Washington

The Washington State Liquor and Cannabis Board (LCB) announced rule revisions yesterday that change many aspects of the Washington cannabis industry, including new product recall procedures for several different scenarios.

Hilary Bricken of the Canna Law Blog notes that under the LCB’s new rules, there will be three possible scenarios that could result in a product recall: exempt market withdrawals, in which licensees would recall a product over aesthetic or packaging issues; licensee-initiated recalls, wherein licensed producers and processors are expected to voluntarily withdraw products that contain contaminants or restricted pesticides; and board investigation-initiated recalls, which would only occur whenever a licensee “fails to engage in re­call efforts that meet the urgency of the risk to public health and safety.”

The LCB also removed language from the state’s marijuana rules that served as a total destruction stipulation for producers and processors whose products fail initial testing. Now, Board-issued penalties for producers and processors are purely monetary. This is particularly beneficial for Washington’s outdoor cannabis growers, who have been haunted since the market’s launch by the fact that a single failed test could result in the mandated destruction of their entire plot.

Here are a few other rule changes that the LCB identified in an email issued yesterday:

  • Revised the definition of “licensed premises” to include all areas of a premises where the licensee has leasehold rights and any vehicle assigned to transport marijuana;

  • Removed the requirement that “Mr. Yuk” stickers must be on all labels for marijuana infused edible solid and liquid products. The Board will work with the Washington State Poison Center to create a new indicator for marijuana infused products;

  • Added language that failure to address monetary penalties for two or more violation notices in a three year period will result in license cancellation. Licensees failing to respond to a violation or have outstanding fines shall not be eligible to renew;

End


Boston MMJ Advocacy Group Complaint Leads to City Council Process Changes   

Boston medical marijuana advocates say the City Council broke state open meeting laws by failing to provide the public 48-hour notice before a vote that ultimately approved buffer zone regulations for dispensaries, according to a Boston Globe report.

The Massachusetts Patient Advocacy Alliance accused the council of violating the law, prompting the city’s Law Department to send a letter to the state attorney general’s office acknowledging the “mistake.”    

In the letter, Adam Cedarbaum, on behalf of Law Department, said a typographical error was responsible for the wrong item being copied onto the agenda. City Council agendas will now be inspected by a proofreader to reduce future mistakes.

The city clerk caught the error and corrected the online version about 90 minutes after the agenda was posted, the letter said.

In their complaint, the patient group asked that the council take another vote on the plan and allow the customary public comment period. Instead, the Law Department proposed the group be given “ample notice of any opportunity to provide comment before any city commission or agency takes a binding vote or recommendation on the matter.”

The group will consult its advisory board before taking additional steps, Nichole Snow, executive director of the alliance said.

The measure would require dispensaries to be at least a half a mile apart. It would have to be approved by the Boston Redevelopment Authority and the Zoning Commission, and signed by Mayor Martin J. Walsh (D), to take effect.       

End


Global Leaders Will Discuss World Drug Problem & International Reform This 4/20

A ground-breaking 4/20 may be ahead of us as the United Nations General Assembly prepares for a special session to address global substance abuse issues. This will be the first time in almost 20 years that the UN will seriously review global drug policies, of which marijuana will be a major discussion point.

The United Nations General Assembly Special Session (UNGASS) will take place in New York from April 19 to April 21, and will be attended by numerous world leaders and heads of state to discuss global substance abuse and drug trafficking issues as well as three international drug control treaties that have notoriously stood in the way of global marijuana reform.

Though the underlying theme of the assembly will be to support the rights of individual countries to determine their own drug policies, the assistant secretary for the Bureau of International Narcotics and Law Enforcement Affairs, William Brownfield suggested that the Obama administration may actively push for drug policy reform instead of simply tolerating it.   

According to statements made by Brownfield during a press conference earlier this month,

“We will call for pragmatic and concrete criminal justice reform, areas such as alternatives to incarceration or drug courts, or sentencing reform. In other words, as President Obama has said many times publicly, to decriminalize much of the basic behavior in drug consumption in order to focus scarce law enforcement resources on the greater challenge of the large transnational criminal organizations.”

The three-day event will involve plenary meetings featuring statements by many high-ranking authorities including the President of the General Assembly, the Chair of the Commission on Narcotic Drugs, the Director-General of the World Health Organization and the President of the International Narcotics Control Board.

The conference will also include the participation of numerous high-level ministerial heads, medical experts, youth advocacy representatives, and members of the scientific and academic communities. Each participant will represent the best interests of their demographic in five, multi-stakeholder roundtable discussions. All participants will be encouraged to engage in the discussion, but will be limited to three to five minutes to present their stance so as not to interfere with the interactive nature of the event. Each roundtable will consist of five panelists and two co-chairs, each of which must be nominated to participate.

Numerous side events will occur simultaneously with the event, each outlining specific details about current global drug policies and their impact on society. They will look at statistics, trends and research pertaining to drug policies in terms of public health, sustainability and the effectiveness of current drug policy models.

Participation in side events is limited to representatives of non-government organizations who are actively working on drug related matters including the scientific and academic communities, civil society and youth group representatives. Anyone wishing to attend the UNGASS or any of its side events must register online before March 28, 2016.

The plenary meetings and interactive roundtables will be webcast live beginning at 10:00 am EST on Tuesday, April 19, 2016.

End


Portland Harborside Health Center

Recently, the Ganjapreneur team got to tour the newest Harborside Health Center cannabis dispensary, located in Portland, OR.

The original Harborside opened in 2006 in Oakland, California and has played a significant role in establishing standards for dispensaries and consultative care. The Oakland location was the first in the nation to support education for seniors, veterans and families with severely ill children; first in the country to offer CBD-rich medicine; and the first to treat children with Dravet syndrome. The dispensaries, led by cannabis thought leader and activist Steve DeAngelo, raise the bar for quality cannabis medicine and customer service in every city they open in.

harborside2

The dispensary in Portland is cheerfully painted, welcoming and has plenty of free parking. The waiting room is warm and the greeting staff are quick to smile and ask how they can be of service. A second door leads to the dispensary itself which is immediately invigorating.

harborside4

So often dispensaries are dreary affairs that feel claustrophobic and instill a feeling of distrust. Not so at Harborside. The high ceiling, elegant lighting and soothing furniture caused us to stop a moment to just soak it all in. This is clearly a destination dispensary built to make the statement that their meds are reliable and well-considered.

harborside3

As your eyes scan the room, their array of clones pop out bright green under fluorescent lights, giving the whole room a pleasant glow. One of the coolest aspects of this dispensary is the long glass topped table displaying all of the flowers that are no longer in stock.

harborside6

Not only is it simply delightful to view all of the strains gone by, but it is visually arresting to become aware of the sheer variety of medicine that has come through these doors. Always bringing in the best medical growers have to offer and the recent coolest strains too, the display case reminds you why Harborside is a world leader.

harborside8

The case showing what was available on the day we visited was packed with excellent expressions of some of our favorite strains and many that we were not familiar with. The nice, tight and colorful nugs looked like they had fallen out of a magazine even though it was simply their daily stock.

harborside7

Everything was lab tested as well to ensure potency for accurate dosing. The budtender on duty was exceptionally knowledgeable in both botany and health care and provided excellent feedback for us. They also carried an array of edibles, tinctures and concentrates in really well-designed packages, increasing confidence in the products.

harborside5

The dispensary manager Chris Helton came over to say hello and answer questions — what a sweetheart. Chris’s calm and warm demeanor made everyone feel welcome. He even put our conversation on hold to walk over and make sure newly arriving patients and customers were feeling welcome and served as well. Chris let us know about their positive relationship with the neighboring community and the free community pea patch out behind the dispensary. He has worked hard to make sure that Harborside would be a good neighbor to the existing shops who were a bit concerned about having a dispensary in the neighborhood. Now, everything has come together and the locals see the new dispensary as a welcome addition.

We have become fans of the Portland Harborside cannabis dispensary and look forward to our return visit soon. If you would like to learn more about founder Steve DeAngelo’s vision for compassionate care, you can listen to Steve’s appearance on the Ganjapreneur podcast.

Visit the Harborside Health Center:

5816 NE Portland Hwy
Portland, OR 97218
11am-9pm daily
(503) 912-4372
http://www.harborsidehealthcenter.com/Portland/

End


Nixon Official Admits Drug War Was a Hoax

A 1994 quote from a former Nixon aide makes it crystal clear that the administration’s reason for criminalizing drug use was purely to throw into disarray Black communities and the anti-war movement.

John Ehrlichman was serving as President Nixon’s chief domestic policy advisor when Nixon announced the roll-out of the War on Drugs. In seeking a massive expansion of federal drug agencies, the Nixon administration cited the pernicious impacts of drugs on social welfare.

The drug war has had ruinous economic and social consequences for the United States, Mexico, and Latin American countries, consequences which are especially pronounced for racial minorities.

Reporter Dan Baum spoke with Ehrlichman in 1994 while doing research for a book on drug prohibition. Ehrlichman, who served 18 months in prison for his involvement in the Watergate scandal, was frank about the Nixon administration’s motives in inaugurating the drug war. Baum writes in Harper’s cover story this April:

‘You want to know what this was really all about?’ he asked with the bluntness of a man who, after public disgrace and a stretch in federal prison, had little left to protect. ‘The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or Black, but by getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.’

Criminalizing drug use had nothing to do with ensuring social welfare. The racist and paranoid Nixon administration wanted desperately to dismantle two populations: the Black community and the anti-war movement. The easiest way to do so was to criminalize behaviors common to them both.

Baum didn’t include this quote in his 1996 book, Smoke and Mirrors: The War on Drugs and the Politics of Failure, which contains no authorial interviews, but he did put it in the Harper’s cover story, “Legalize It All,” which puts forward a case for drug legalization.

The fact that the drug war was fabricated with malicious intent might not surprise everyone. We hope, though, that the news will sway prohibitionists to adopt a more rational stance.

End


New Jersey Panel Considers Expanding List of MMJ Qualifying Conditions

The health commissioner of New Jersey has put in place a panel that will decide whether various ailments should be included in the list of qualifying conditions for medical cannabis in the state, Philly.com reports.

Patients and advocates have been working for nearly four years to get more ailments added to the list of conditions, arguing that the list is severely restrictive and penalizes sick citizens who have no other viable recourse to obtain effective treatment.

Currently, the list of qualifying conditions for medical cannabis in New Jersey includes multiple sclerosis, epilepsy, HIV, AIDS, cancer associated with severe or chronic pain, glaucoma, Crohn’s disease, and terminal illnesses. Patients can purchase up to two ounces of cannabis each month with a recommendation from a qualified physician.

Patient advocates hope to see chronic pain, post-traumatic stress disorder, and other conditions added to that list.

Governor Chris Christie has repeatedly stated that he is opposed to any legislation that would expand the medical cannabis program, which he fears is a ploy to move toward legalizing recreational marijuana.

Ken Wolski, who heads the Coalition for Medical Marijuana New Jersey, said that although he is glad the panel has been formed, he doesn’t expect much to come of it, noting that the panel members lack the requisite expertise in medical cannabis.

Only one of the five doctors on the panel, Cheryl A. Kennedy, is among those who recommend medical cannabis to patients. Only 450 doctors in New Jersey currently participate in the medical cannabis program.

End


Colin Bell: From Academic to Entrepreneur

Colin Bell, PhD. is the co-founder, co-inventor, and chief growth officer of Growcentia, a manufacturer of organic soil supplements designed to minimize environmental impact. In his previous career as a research scientist at Colorado State University, Colin focused on understanding plant microbial interactions and produced many peer-reviewed publications on microbial mediated processes to enhance plant growth. With Growcentia, he has taken his scientific knowledge and applied it to business, solving real problems faced by farmers who want to grow better crops via sustainable methods.

Colin recently joined our host Shango Los for a conversation about the transition from academic to entrepreneur, how he manages work/life balance, how he fosters teamwork and camaraderie among coworkers in a start-up environment, and more.

Listen to the episode using the media player below, or scroll down for the full transcript!

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


 

Listen to the podcast:


 

Read the full transcript:

Shango Los: Hi there and welcome to the Ganjapreneur.com podcast. I am your host Shango Los. The Ganjapreneur.com podcast gives us an opportunity to speak directly to entrepreneurs, cannabis growers, product developers, and cannabis medicine researchers all focused on making the most of cannabis normalization. As your host, I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark, and give you actionable information to improve your business strategy and improve your health and the health of cannabis patients everywhere.

Today my guest is Colin Bell. PhD, co-founder, co-inventor, and chief growth officer for Growcentia. Colin received his PhD in 2009 in soil microbial ecology. His academic research was focused on understanding plant microbial interactions, and soil microbial biogeochemical cycling. As a research scientist at Colorado State University, his many peer reviewed publications were centered on elucidating microbial mediated processes that enhance plant growth.

Colin left his academic position at CSU in March of 2015 to launch his startup company Growcentia. Their first product, MAMMOTH P, is a beneficial bacteria bloom stimulant that targets phosphorus cycling to maximize both quality and yield in cannabis plants. Today we’re going to talk about making a leap from academic to entrepreneur. Thanks for being on the show, Colin.

Colin Bell: Thanks Shango, how’s it going?

Shango Los: It’s going really great. I’m excited to have you on the show because a lot of people are doing one thing, and they really in their heart wish they were doing something else, specifically being an entrepreneur. I’m excited to talk about the travel that you’ve taken, so that maybe it inspires some others. Let’s get started by really cementing you in the academic world. What were you doing at CSU, and kind of steep us in that a little bit.

Colin Bell: Great. I’ll start, like you said, I received my PhD in soil microbial ecology in 2009 after doing a couple post docs with on the USDA and the Forest Service in Fort Collins, Colorado. I achieved my third post doc at Colorado State University working with my team Matt Wallenstein and Rich Conant, who are also co-founders with Growcentia.

After a couple of years I got promoted to research scientist 1, where the whole time and my whole academic career and my graduate career also was focused on understanding plant microbe interactions, and understanding nutrient cycle. Like we said, to kind of understand how plants and microbes have evolved together and how microbes might benefit plants, in light of climate change or anything else, to help promote their growth and their success. We just did that. That was kind of my dream, to be an academic research scientist at the Natural Resource Ecology lab at Colorado State University. We were very successful there for years.

One day, kind of how it came about is, we decided that all the publications that our team had been pushing out, which was many, many, we questioned the impact we were making in academia. We always felt that our research would really help agriculture in general, and improve agriculture sustainability, and our technology ultimately, or our knowledge and our publications that we provide to the scientific community would translate to improved management practices for more sustainable, natural ways for plants to grow, to improve yield to feed the globe, the growing population, the world. Thinking that one day, out of all the papers and all the grants that we wrote. We have this broader impact statement that all the grants require.

We talk about how our research is going to impact agriculture and farmers and help farmers grow better. We kind of came to the realization that farmers probably weren’t reading our publications. As a matter of fact, it validated that. We decided that to be hiring a pack of scientists, we should start focusing more on applied problems to try and get our technology in the hands and in the forum that farmers could use in this lifetime. That’s when we switched the lab, flipped the lab, started thinking about problems, and thinking about applying our knowledge into making something that could be applied into agriculture practices. Reshape the labs, started thinking about it from the perspective of a soil microbial ecologist and what microbes do well, and how to produce that and scale that. You know what microbes do do well, is cycle nutrients and provide nutrients to plants among other things. That’s why plants and microbes have evolved together basically since the beginning of time.

Shango Los: Before we get too much into talking about the product itself, I want to talk about the lab a little bit. You’re talking about being within academia at that point. I’m sure that there’s a fine line between you are doing the research under the auspices of the school, but then there’s a certain point where suddenly you are actually becoming a business, which is, I don’t know, not usually the role of what the school is looking for. They’re often going for pure research. I could be wrong, maybe schools now are actually trying to roll out these products. How did you skirt that line between running your lab as a research lab versus coming up with the preparations to put a product onto the market.

Colin Bell: That’s a great question. Honestly, the truth is even a decade ago universities were focused on basic research. That’s kind of the structure. The infrastructure, truly, is still like that, but there’s a great push and a much improved emphasis on actually launching technology from the lab into the marketplace. I think it was helpful. Most universities now have tech transfer departments that focus specifically on helping researchers understand how to bridge that gap between the scientific lab and the marketplace.

I think there’s definitely a lot of work to do and a lot of progress to be made, but there has been a lot of progress made certainly in the last decade. How we did that really is working with our tech transfer department at Colorado State University and going through some rigorous incubators, business incubators. For example, the NSF I-Corps accepted us as a team. The NSF I-Corps program is a brilliant program developed by the national government, the NSF, to help researchers understand specifically how to identify the value of the technology that they’re developing potentially in the lab, and what it takes to launch that into a marketplace.

That was a rigorous training based on lean start-up methodologies of Steve Blank and some others, where we basically treated this exercise like an experiment. We had these hypothesis of value, and we had these hypothesis of customer segments. The way we validated that is we hypothesized there was particular value for whatever product. Our particular product was enhancing nutrient uptake to plants that ultimately enhance yield. We had that early stage, and we were very naive going into this, assuming that farmers would buy this type of product. The exercise is if you think you have a value and you think, you hypothesize, you have a customer segment, what you should do now is go talk to a hundred of those customer segment archetypes, farmers in this case, to validate if you’re right or not.

Shango Los: It sounds like you’re actually making almost your own focus group. You’re making your hypothesis, and I love hearing basic marketing repeated to me in lab speak. I’m enjoying this a lot. But also you would then go out and talk to your hundred subjects, and then you would be building up your own data base specific to your own product.

Colin Bell: That’s exactly right. What we’re trying to do is validate the value propositions that we think our product would bring to market. Through that process it was just invaluable, because we realized very quickly where we were wrong. We realized very quickly what the value was, with any particular agriculture market segment, that our product would need to meet to be a successful product to launch into the marketplace.

For example, if you talk to producers in the larger agro space, such as corn farmers and wheat farmers, et cetera, no matter what you think your product does to enhance the environment, et. We were kind of thinking about our product from an ecological standpoint also. It’s a natural microbial additive that improves nutrient use, but also it would allow us to potentially minimize inputs, which are sometimes caustic to the environment, such as excessive fertilizer, etc. We didn’t emphasize yield as a value proposition early on in our discovery. What we realized is that was the only thing almost that mattered to be able to successfully launch our product into the marketplace. That was the key value proposition for most agriculture market segments.

Shango Los: I would think that that is actually probably one of the reasons that you’ve had so much success early on. We’ll talk more about the success of the product in a minute. But specifically the fact that many entrepreneurs will come up with the idea, they’ll be passionate about it, and then they’ll go to the market with what their hunch is, but because you came at it as an academic scientist you’re like, “Well, I wouldn’t go to the market before I test my hypothesis,” and so you created your own study by going out and talking to these hundred farmers, which gave you all this new focus group information which becomes your new evidence. I would think that if most entrepreneurs would do that in their own way, we’d see a lot less failing companies.

Colin Bell: That’s exactly right. It’s called the lean start-up approach, and that’s exactly what I think you should do. I think you nailed it. Most startups fail because they haven’t rigorously validated the value and/or the customer segments that need that value, what we look for as pain points. What can that customer not live without? If your product can fill that pain point, you know you definitely have a successful product, but you have to validate it.

Shango Los: Thanks Colin. We’re going to take a short break and be right back. You are listening to the Ganjapreneur.com podcast.

Welcome back, you are listening to the Ganjapreneur.com podcast. I’m your host Shango Los, and our guest this week is Colin Bell of Growcentia. Colin, before the break we were talking about your background in academia and how deeply you were involved as a research scientist, and how the research that you were doing was going to help farmers, but you weren’t sure how the farmers were going to find out about it. You shifted your research into going past just developing what the farmers could do, and figuring out how to get your research into the hands of farmers by way of a product possibly. That brings us to where we are now.

The first product that Growcentia has put out is the Mammoth P. Can you tell us what is unique about this product that caused you in academia to go, “Wait a minute, this is something new and this could actually do good”?

Colin Bell: Sure. We are really excited about MAMMOTH P early on, and still. We are really excited that the technology because it’s so unique. The way we were thinking about developing a new microbial biostimulant product to enhance plant growth was just something that no other company, or any other lab for that matter, has come up with. What we wanted to do was target functionality at the microbial community level.

We wanted to work with microbial communities because we know in nature microbial species just don’t persist. They have to persist and function as a community. What we also want to do was train functionality for specific nutrient cycling. That way, we thought over time we could actually prescribe different microbial inoculants to treat certain deficiencies of nutrients, such as phosphorus or nitrogen. Our first product, MAMMOTH P, is a microbial community that specifically targets phosphorus, which means it liberates phosphorus as it’s bound in soylent substrates, which happens naturally almost immediately once phosphorus is added into soil, potting mix. It even chemically transforms into plant unavailable forms in hydroponic systems. We were able to train, using our proprietary microbial trait selection platform, to train microbial communities to increase their ability to cycle phosphorus by up to 30 times greater than any natural communities that we’ve found in nature.

Shango Los: To put it in my own terms, what it sounds like is phosphorus is going to be naturally occurring in the soil, but there are challenges for uptake for the plant. What you have done is you’ve put together a community of specially chosen microbes that when you introduce them to the soil, they do the job of unhinging the phosphorus from wherever they’re tied down, to become more bioavailable for your plant so your plant is able to thrive with more phosphorus, because it’s so much easier for it to get it out of the buffet in the soil. Is that a good way to put it?

Colin Bell: Yeah, I think that’s very well said. Nice job there. That’s exactly what it is. We find that the plants are able to take up a lot more phosphorus with our additive which enhances the plants ability to improve their bloom or yield, no matter what that plant might be. In the case of cannabis, it actually translocates phosphorus and micronutrients to higher levels than the plant could without our inoculum enhancing bloom growth and the density and the quality of the flower.

Shango Los: I have a feeling that your answer to this next question’s going to be over your head, but I’m dying to hear the answer anyway. I would love to hear you contrast how phosphorus is normally taken from the plant, what that process is like, compared to when you use your microbial communities. Kind of illustrates for us the difference, the value proposition, of why the microbial works so much better.

Colin Bell: In processing, now we identified this problem actually in natural agriculture soils, which is a prolific problem across the country. When farmers add phosphorus fertilizer to soils, up to 70% becomes almost immediately unavailable to plants because phosphorus binds, it’s chemically sticky, to minerals and carbon substrates alike. Phosphorus will immediately transform, once it hits a substrate, into plant unavailable forms. It’s a really unique and interesting ecological problem, because farmers really need, of all crops, really need plants that take up as much phosphorus as possible. Across all crops, phosphorus is in high demand, especially during the yield or flower cycles of the plant.

Over time, the phosphorus will continue to build up —let’s just talk about agro ecosystems right now — for up to two decades, where the exchange sites will keep on getting stuck with these phosphates, which is a plant available form of phosphorus, until over time the soil saturates and then flushes through the environment and creates huge ecological problems like algal blooms that we see quite often, polluting water ways, etc.

What this microbial community does is we’ve improved their capabilities to solubilize, which means exchange, those phosphorus molecules that were bound to the soil back into the solution in the plant available form phosphate PO4, which allows the plant to take up as much phosphorus as possible, mining those phosphates as they’re bound to soils and substrates alike. This happens even in hydroponic systems, and prolifically in cocoa, and peat, and soil systems as well.

Shango Los: Great. I followed that. I want to change gears for a second here. Now that we understand the importance of the product and why you were so excited to make the jump from academia to the entrepreneurial side, tell us a little bit about how you chose to then actually form the company. I’m holding a bottle of your product in my hand, and it is gorgeous. The design is great, the copywriting is great. Whoever laid out your branded colors. It’s an incredible, branded experience which you really don’t see all that much in the cannabis industry, or maybe we are just now starting to. You must have put some work into building the idea of the company around the product that you were feeling jazzed about.

Colin Bell: That’s right. I think what I have to emphasize for sure is nothing happens alone. We have a wonderful team helping us in every area of our business. Not only do I have wonderful and brilliant co-founders, but we hired a CEO that flew all the way from Chicago to be with us here in Fort Collins, Colorado, that’s grown many start-ups from the very beginning to multi-hundred million dollar companies. We have a great team on the ground, in all our packaging production. We talk about branding and marketing, we have consultants here, local in Fort Collins, Colorado, to help us with our social media. Another one Push IQ Chris Richardson, that helps us with our branding.

We also have a great list of external advisors, including the CEO of New Belgium and a former employee of theirs, Greg Owsley, which actually branded the New Belgium Fat Tire brand from their early days, which helped them be a very successful global company. Really, I didn’t do anything by myself. I surrounded myself and our ideas. We all want to be the dumbest person in the room. If we’re that, then we can really bring talent around the table to help us come up with these great ideas.

What we want to do for this is own our culture. We’re a scientific, highly technical company. The three co-founders including myself are PhD soil microbiologists. My other two co-founders are still faculty at Colorado State University. We wanted to be distinguished in every way we possibly could. We felt that clean brand, the white label with the mammoth, which is super iconic, really stood out and really kind of illustrated who we were as a company.

Shango Los: It is a good thing to surround ourselves with the people who are smarter than us when we’re building a company. The group that you have pulled together is pretty extraordinary though. I’m curious, were these people that were already in your network, because you are naturally a networker as an academic, or is it just that all of these people are smart enough to live in Fort Collins, Colorado, or is this something that people were attracted into your sphere of influence because of the incubator?

Colin Bell: I think a little bit of everything. We didn’t have these people in our lives before we started Growcentia, but what we do do is reach out to a lot of people. We present people with good opportunities. I think people see a good thing, the good thing that we’ve done with Growcentia, and that’s basically create a really interesting product in a very, very interesting market. We have some really compelling values. Not only do we have a wonderful product, but we have a wonderful platform that allows us to create a family of products.

Not only are we in this wonderful, very exciting market, which is projected to do just amazing things, we’re at the very base of something, that we think we can grow with the cannabis market as it grows. That’s very exciting. Our product is very well positioned to bring value into other markets too. That kind of started also with our investors M34. We were able, after three incubators, to bring on an early seed investment which allowed us to launch the company. That’s when I left the university, in March of 2015, to start the company.

Like I said, when you have a great story- I mean, my son and I found an old transmission shop here in Fort Collins, Colorado. We cleaned it out, we painted it, we mopped the floors 30 times, and turned it into our bio-production facility. Before that, I was working out of my one car garage that I quickly scaled out of after my first shipment of bottles came, and two pallets got dropped in my driveway and blocked the cars from coming in. It was really lean start-up, I think, really compelling our team. Obviously, very compelling. We’re all a driven group that wants to have a lot of fun and do great things.

Shango Los: Right on. We’re going to take another short break and be right back. You are listening to the ganjapreneur.com podcast.

Welcome back. You are listening to the Ganjapreneur.com podcast. I’m your host Shango Los, and our guest this week us Colin Bell of Growcentia. In the last segment, we were talking about specifically Growcentia’s first product, MAMMOTH P, and why it is unique, and more importantly why it caused Colin to decide to leave academia to become an entrepreneur and back it up. One of the things I really enjoyed when we were talking about bringing your product to market, Colin, was the interesting way you used lean to go out into the field and make sure your customers wanted your product before you went to the trouble of bringing the product to market.

When I was hearing that, it also made me wonder how you, as a research scientist, approached life work balance, because just like many entrepreneurs who go to market with a product that they haven’t actually market tested yet, they’re going really on passionate intuition and luck. You didn’t go that way, you wanted data, hard data, before you took your product to market. How do you handle work life balance, right? I’ve a feeling that you might have schematics drawn up to help you do that.

Colin Bell: Such a great question. It’s such an incredible challenge, especially for myself. I think for most of us in academia, we’re such a driven team and driven individuals. I think getting your PhD, going through that process, kind of weeds out the people that aren’t just kind of really obsessively driven to push, push, push. Saying that, what I realized, especially after I left the lab and left academia and started this start-up, was there’s never enough hours in the day. If you don’t take time for yourself no one else will, and that’s really unsustainable. I’ve made it a goal, and it’s really a professional goal, that we write out every year, or every quarter, if we’re not accomplishing it, to make sure not only we’re accomplishing our benchmarks and our goals professionally and internally with Growcentia, but that we have a whole list of personal goals and needs that we meet on a regular basis also.

For me personally, and my whole team, especially the co-founders, we love to ride our bikes. I personally like to run. We try to stay fit. Fort Collins is a nice environment to do that for sure. That’s what I really do, I incorporate — I’m kind of a boring guy. I work a lot and I work out a lot, and I try and have some downtime. I’m trying to balance all those things, but I need friends, I need family, I need fitness. I definitely need success in every area of my life, and that’s in all my relationships, especially with work. Ultimately, if I’m happy, I’ve succeeded. All these things in my life make me happy, and fulfill me, and so that’s what I do. I could just keep on doing that.

Shango Los: A couple shows ago, we had on Tom Burns, he’s a business philosopher who started as a yogi and is now in the cannabis business, and he says, “First, you feel good, and then you do good.” There’s a lot of that in what you just said. I also think it helps with working all the extra hours that you almost always have to do with a start-up, since fitness is one of your key things. So many entrepreneurs, they get busy, suddenly they’re not eating properly, and they’re not getting their exercise. Not only are they pushing their bodies harder with more stress and more awake time, but then they’re also not feeding the body what it needs. I would think that having a fitness regimen that you actually share with your co-workers, so you’re being supported in it, that’s probably a really great secret to success.

Colin Bell: I think so. I mean, I feel the success whenever we can do that. Actually, we have daily squat jumps and push ups and pull ups as a team in the lab, or we’ll have ten people or fifteen people in the back of the production facility, “Okay,” we’ll yell, “All right, it’s time!” We have monthly goals where we up that. We’re all jumping around, doing our squat jumps and push ups. But you know what? We all enjoy it, and it just makes us feel better, gets the blood flowing, and a sense of camaraderie and progress.

Shango Los: Oh man, this interview’s going to get you so many job inquiries it’s ridiculous, it sounds like a great place to work.

Colin Bell: Sure.

Shango Los: I want to hit one more thing. We’re almost out of time here, but one of the things that I don’t know anything about, like for example, I wasn’t too deep when you talked about your university having a tech transfer department, that’s pretty cool. That’s a new thing since I left school. What happens with the income? Since you came up with the ideas at the school in the research lab do they get a part of it, or is it they like to have the reputation of spinning off new technologies and businesses? How does that work?

Colin Bell: That’s kind of a big conversation, but in brief, and it in most universities …

Shango Los: Yeah, can you do it in 90 seconds?

Colin Bell: Yeah, yeah. Universities, if you go look at technology at the university, university actually owns that technology. As a research scientist that developed a technology that launched into the marketplace, I had to license the technology, and we did successfully, from the university. The university gets part ownership in that technology for sure. We went ahead and patented that technology so we could protect it in the marketplace, and we launched it. Colorado State University is a true partner with us in this process, being the owner of the technology. Future technology, as you launch your company and you’re in the private sector, you’re going to develop more technology which you would probably own as a company. That’s the path that most people follow whenever they actually launch a company and they’re at one point separated from the university autonomously, if you will.

Shango Los: Right on. Well, for being a really big topic you actually distilled that business model really simply, so thank you for that. That’s really interesting. That’s also all the time that we’ve got today. Colin, thank you so much for coming on the show and sharing your experience. I’m sure that you have inspired a lot of people to consider making that job.

Colin Bell: It was a pleasure, it was really fun to be here. Thank you very much for having me.

Shango Los: You can find out more about Colin Bell and MAMMOTH P at their website, mammothmicrobes.com, M-A-M-M-O-T-H-M-I-C-R-O-B-E-S.com. You can find more episodes of the Ganjapreneur Podcast in the podcast section at Ganjapreneur.com, and in the Apple iTunes Store. On the Ganjapreneur.com website, you will find the latest cannabis news, product reviews, and cannabis jobs updated daily, along with transcriptions of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. You can also find this show on the iHeartRadio network app, bringing Ganjapreneur to 60 million mobile devices. Do you have a company that wants to reach our national audience of cannabis enthusiasts? Email grow@ganjapreneur.com to find out how. Thanks to Brasco for producing our show. I’m your host, Shango Los.

End


New CDC Guidelines Urge Doctors to Stop Drug Testing Patients for Cannabis

The Centers for Disease Control and Prevention (CDC) have recommended via a new set of opioid-prescription guidelines that doctors stop urine testing their patients for THC, the psychoactive compound specific to cannabis.

According to the guidelines:

“Clinicians should not test for substances for which results would not affect patient management or for which implications for patient management are unclear. For example, experts noted that there might be uncertainty about the clinical implications of a positive urine drug test for tetrahyrdocannabinol (THC).”

The guidelines also urge doctors not to drop patients if they test positive for THC, which — according to the Pain News Network — is one reason that many marijuana users have been discharged from their physicians’ care.

“Clinicians should not dismiss patients from care based on a urine drug test result because this could constitute patient abandonment and could have adverse consequences for patient safety, potentially including the patient obtaining opioids from alternative sources and the clinician missing opportunities to facilitate treatment for substance use disorder.”

It’s always nice when federal establishments recognize the banality of marijuana prohibition and all of its unfortunate baggage, but it’s official changes like these that ultimately will umbrella cannabis treatment into mainstream medical practices.

Studies have shown that the rate of overdoses involving prescription drugs is significantly reduced in states with medical marijuana laws. However, with nearly 50,000 overdose victims in 2014, prescription opioids have never posed more of a threat to U.S. citizens than now.

End


Richard Branson Investigates Benefits of Colorado Cannabis Taxes

English business magnate and corporate mogul Richard Branson requested a tour of a non-disclosed substance abuse facility in Colorado last week, so that he could witness first-hand how Colorado is spending some of its cannabis-derived taxes, Ricardo Baca reports for The Cannabist.

Branson was in Colorado last week to celebrate the launch of his Virgin America airline’s services in Denver. Before leaving the land of legal marijuana, however, the self-made billionaire decided check in with some of the state’s top pot officials and industry professionals.

“There was never a blanket statement of why he was there, but we do know that Mr. Branson is interested in drug reform policy that prioritizes treatment over criminal penalties,” Robert Thompson, public information officer for the Colorado Department of Human Services, told The Cannabist.

“He wanted to learn about how things are going in Colorado with the legalization of marijuana, how things were going with collecting taxes and distributing taxes, and looking at the programs that benefit from marijuana tax dollars, including the one he toured,” Thompson said.

Branson has long been a vocal advocate for international drug policy reform, and serves on the Honorary Board for the Drug Policy Alliance.

In a blog post from 2015, he wrote that “Drugs should be treated as a health issue … so that the millions who continue to be harmed by current policies can be helped instead.”

In a 2012 op-ed for CNN, he wrote, “Rather than continuing on the disastrous path of the war on drugs, we need to look at what works and what doesn’t in terms of real evidence and data.”

End


Ohio Lawmaker to Introduce Medical Cannabis Legislation

Ohio Sen. Kenny Yuko (D-Richmond Heights) will introduce legislation in the next few weeks that could establish a legal system for medical cannabis access in Ohio, he announced this week in an interview with Cleveland.com.

There are currently few details revealed about Sen. Yuko’s bill, but it has been specified that individuals with certain medical conditions — including severe epilepsy and post traumatic stress syndrome (PTSD) — would be allowed to use medical cannabis if issued a recommendation from a doctor who “has a history of treating the patient.”

“It’s a piece of legislation that most people who are reading it are finding palatable and are supportive of it,” said Sen. Yuko.

Ohio has recently become a hotbed for talks of cannabis reform, and following last year’s failure of a controversial recreational legalization push by the advocacy group ResponsibleOhio, the group teamed up with the Marijuana Policy Project on a medical cannabis initiative that is expected to appear on the ballot this November.

Approval ratings are generally very high for medical cannabis among Ohio voters — even Republicans in the legislature have announced hesitant support for reforming the state’s marijuana laws.

According to Sen. Yuko, his proposal would ideally be approved and pushed through by the time the legislative session ends in June, or else lawmakers wouldn’t be able to address the subject again before voters take control of the process come November.

End


Kentucky Hemp Farmers Expanding Operations, Tennessee Farmers Shying Away

Farmers in Kentucky and Tennessee are seeing vastly different results in their respective industrial hemp markets.

The Kentucky Department of Agriculture has authorized 4,500 acres of hemp production this year – the third year testing its viability as a cash crop in the state, according to an Associated Press report. Last year the pilot program saw 900 acres of hemp grown after just 33 total acres in 2014.

“Hemp is a bridge from Kentucky’s past to our future,” Ryan Quarles, Agriculture Department commissioner, said in the report. “The Kentucky Department of Agriculture and our partners are committed to building upon the solid foundation of research for a Kentucky hemp industry that will create jobs and new marketing opportunities.”

Meanwhile, in border-state Tennessee, just 25 farmers have signed up to produce hemp, down from the 50 who signed up last year, the AP reported. The low enrollment is likely due to low, or nonexistent, profits by farmers who took a shot on the crop during the first year of the pilot program.

Chuck Mason, a Cook County farmer, said the crop turned out to be a bust after his hemp seeds were more than a month late following customs delays and he was “just not willing” to take another chance on the crop. Mason said he will return to growing hay.

Tennessee charges $254 for a permit to grow hemp, and one farmer, Wayne Smith of Washington County, said he was offered $7 for his 10-pound seed yield.

“I’m going to use the harvested seed to make oil and maybe sell it as a novelty item,” he said.

Farmers in Tennessee have until April 1 to apply for a permit.

End


SCOTUS Dismisses Lawsuit Filed Against Colorado Cannabis Legalization

The Supreme Court of the United States voted 6-2 on Monday to dismiss a lawsuit that was filed against Colorado by two of its neighboring states for its recently-reformed marijuana laws.

If the justices had chosen to accept the case, the ensuing litigation may have lead to a drawn-out legal battle that could have spanned years.

“This was a meritless lawsuit, and the court made the right decision,” wrote Mason Tvert in a written statement for the Marijuana Policy Project.

“States have every right to regulate the cultivation and sale of marijuana, just as Nebraska and Oklahoma have the right to maintain their failed prohibition policies. Colorado has done more to control marijuana than just about any other state in the nation. It will continue to set an example for other states that are considering similar laws in legislatures and at the ballot box.”

Oklahoma and Nebraska could bring their lawsuit to a federal district court if they wish to continue pursuing the case, but they haven’t announced yet one way or another what their exact intentions are.

Doug Peterson, Attorney General of Nebraska, said that he was disappointed in the court’s ruling and that his office will be “working with its partners in Oklahoma and other states to determine the best next steps toward vindicating the rule of law.”

End


New York Assembly Budget Proposal Would Expand State’s MMJ Program

Under the New York State Assembly’s budget proposal, the state’s medical marijuana program would be expanded, according to an Albany Business Review report.

If enacted, the program could see more registered organizations, more doctors and a doubling of the number of dispensaries an organization is allowed, from four to eight. 

New York’s medical marijuana program is off to a “slower start” than advocates anticipated, which has, according to Assemblyman Richard Gottfreid (D), impaired access options for registered patients.

“As predicted, the law that we enacted and the regulations implemented were made so restrictive by the executive branch that the program is barely off the ground and many patients in need are not being served,” Gottfried said.

Since the program’s January launch, 482 physicians have completed the course allowing them to recommend cannabis, while 1,934 patients have been certified to use the drug as a treatment option, according to March 18 numbers from the state Health Department.

While increasing the number of dispensaries is imperative for the program’s success, and patient access, Vireo Health CEO Ari Hoffnung says allowing more operators isn’t what is needed to combat the slow start.  

“We don’t believe that the most effective way to improve patient access would be increasing the number of registered organizations,” he said in the report. “The way to do that, in our mind, is to make it easier for patients to find doctors and allow for delivery to patients.”

Gottfried and other program supporters are pushing for additions to the list of approved conditions. Under the law, those changes can only be approved by the Health Department.

End


New Orleans City Council Moves Forward With Cannabis Decriminalization

The New Orleans City Council voted unanimously Thursday in approval of an ordinance that lets police give citations for the possession of small amounts of cannabis, rather than being forced to arrest offenders.

Ordinance #31, 148 — which, if approved by Mayor Mitch Landrieu, will become Sec. 54-505 of the NOLA Code — was brought to the legislative table by city councilwoman Susan Guidry.

The ordinance expands upon a 2010 law sponsored by councilwoman Guidry that lets police officers in New Orleans issue a court summons for cannabis possession for first-time offenders.

Guidry had initially pushed for allowing first-time offenders caught in possession of up to 14 grams to be let off with a verbal warning, and second-time offenders given a written warning. A third-time offender would be issued a $50 ticket, and a fourth-timer would be given a $100 ticket.

NOPD Superintendent Michael Harrison questioned the legality of requiring police officers to keep a record of such verbal warnings, as well as the capacity of the policy department to maintain such records.

Guidry’s new ordinance now heads to Mayor Landrieu, whose office has indicated that he is will sign it into law. The ordinance will take effect 90 days after being signed.

“Public safety is our top priority right now, we are hiring and training a larger, more professional police force that will give us the tools required to reduce violent crime, reduce response times and provide our residents and visitors with the security we all deserve. The ordinance will become law,” a statement from the Mayor’s office reads.

End


Oregon Earns $3.48 Million in January Cannabis Sales Tax

Oregon has earned $3.48 million in recreational cannabis sales tax from the month of January, Noelle Crombie reports for The Oregonian.

This number far exceeded expectations. In fact, the state made more money during January than state economists had projected for the entire year.

In total, Oregon dispensaries sold over $14 million worth of recreational pot during the month of January.

“It’s something that probably says there is a high level of compliance and that consumers are choosing to go to the legal establishment and more and more of them are leaving what we term as a gray or black market,” said Mazen Malik, a senior economist for Oregon’s Legislative Revenue Office.

Because the official market has yet to launch, there remain many unknowns for the Oregon recreational cannabis market — including how much the upcoming regulations will cost the state. Tax income may fluctuate, Malik warned.

As of March 4, the Oregon Department of Revenue had received taxes from 253 of the state’s 309 dispensaries that have registered as temporary recreational retailers. Some of these dispensaries during that time may have only been selling medical cannabis, however, which is not taxed in Oregon.

The first 40 percent of Oregon’s recreational cannabis taxes (after the costs of taxation, collection, and regulation have been covered) will go into the Common School Fund. 20 percent will go to mental health, alcoholism and drug services. The Oregon State Police will receive 15 percent, while city and county law enforcement agencies will each receive 10 percent. The final 5 percent will go into the Oregon Health Authority’s efforts to combat drug and alcohol abuse.

End


New Jersey Medical Cannabis Prices Are Nation’s Highest, Report Shows

Patients enrolled in New Jersey’s medical cannabis program are paying about 37 percent more per ounce than their counterparts in states with similar programs, according to a state Health Department report.

The five dispensaries in the state charge an average of $489 per ounce, while the average price at dispensaries in Arizona, New Mexico, Vermont, Maine and Rhode Island is $311 per ounce. The study took into consideration that those five states also have a 10 percent lower cost of living than New Jersey.

The report noted that the Drug Enforcement Agency found that the price of “hydroponic black market marijuana” in the state is around $400 to $450 per ounce.

Taking into consideration that Alternative Treatment Centers are held to rigorous cultivation and production standards in the state – cultivation, packaging and dispensing occur in “sanitary environments” and cannabis is grown without pesticides – the report concluded that “no ATCs are charging excessive prices for medical marijuana.”

“New Jersey medicinal marijuana is regulated and tested, patients are afforded protection under the Act and are able to change ATC affiliation at any time at no cost,” the report said. “ATCs are required to pay federal corporate tax at a rate of 34 percent.”

The 34 percent corporate tax equates to $166.26 per ounce sold at the $489 rate.

In an interview with Philly.com, Michael Nelson, general manager of Compassionate Sciences in Bellmawr, objects to the report’s accuracy. He says it fails to take into consideration monthly discounts and reduced prices for low-income patients, whose final price is closer to $300.

Donna Leusner, spokesperson for the Department of Health, said in the report that in addition to the discounts granted by some dispensaries to certain customers, about 48 percent of program participants receive a discount on their registration fee, cutting it from $200 to $20.         

End


Rhode Island Governor Open to Cannabis Legalization Referendum

Gov. Gina Raimondo is open to the idea of putting the legalization question to Rhode Island voters, she told the Providence Journal on Tuesday.

“I could see Rhode Island eventually getting there,” she said. “But I’m not in a rush because there are issues of safety, how do you regulate it, how do you keep it out of the hands of kids, especially the edibles. I think there probably are some economic advantages to being first, but I’d rather get it right.”

According to Rhode Island state law, in order for the legalization issue to appear before voters at all, the state legislature must be willing to issue a referendum to consult the public — there is not a voter initiative process that advocates can rely on. In other words, the first steps of reform can only come from state lawmakers.

Gov. Raimondo has reportedly been in talks with Colorado’s Gov. John Hickenlooper about the aftereffects of legalization to determine whether or not such a course would be good for Rhode Island.

“I could see the logic in saying it’s the kind of thing that people ought to have a say in … It doesn’t say I’m committed to it, but I’m open to it,” she said.

End


Pennsylvania Legislature Passes Medical Cannabis and Industrial Hemp Bills

Cannabis and its non-psychoactive cousin scored victories in the Pennsylvania legislature yesterday as the House and Senate passed medical marijuana and industrial hemp bills, respectively.

The medical marijuana plan covers patients with 17 chronic conditions, such as cancer, Parkinson’s disease, AIDS and post-traumatic stress disorder. It does not allow for the plant to be smoked, opting instead for the drug to be ingested via pill, oil or liquid, similar to programs in New York and Minnesota. The proposal, which passed 149-43, would permit the state to license up 25 cultivators and 50 dispensaries with three locations each.

“Today we have the opportunity of offering hope to the parents of these children, to the patients, offering the hope of letting them, along with their doctors, decide how to best treat the conditions they’re dealing with on a daily basis,” Rep. Jim Cox (R) said in the Associated Press report.  

Gov. Tom Wolf (D) thanked the legislature in a blog post and continued advocating for a medical marijuana program in the state.

“Soon, we will finally provide the essential help needed by those suffering from seizures, cancer, and other illnesses,” he wrote. “It is long past time to provide this important medical relief to patients and families across the commonwealth, and I thank the quick action by the Pennsylvania House to bring us a huge step closer to legalizing medical marijuana.”

The bill’s next stop is the Senate, where similar legislation was passed 40-7 last May.

Meanwhile, the industrial hemp bill passed by the Senate would authorize higher education institutions in the state to conduct hemp cultivation research pilot programs.

Passing 49-0, Senate Bill 50 builds on a 2014 move by Congress to relax federal restrictions on hemp cultivation as part of the omnibus federal Farm Bill, according to The Daily Chronic.  

Sen. Judy Schwank (D), the bill’s sponsor, said while she didn’t expect hemp to be used commercially for “many years,” the proposal “opens the possibilities for future generations of farmers.”

“Hemp would allow Pennsylvania to be on the same playing field with states that have already passed some form of hemp legislation,” Schwank said in a press release. “The soil and climate here in PA is perfect for growing hemp and hemp got its start in PA. We have townships such as Hempfield Township in Lancaster that were named after the crop and its viability in the area.

The bill has not had a ‘nay’ vote yet, passing through the Senate Agriculture & Rural Affairs Committee 11-0 last October.

End


Canadian Activist Pledges to Give Away One Million Seeds for Cannabis ‘Victory Gardens’

Renowned Canadian marijuana activist Dana Larsen has pledged to give away more than million pot seeds to help Canadian medical cannabis patients everywhere plant and grow their own “victory gardens” this spring.

Larsen was a founding member of the BC Marijuana Party, the Canadian Marijuana Party, and founded the Vancouver Dispensary Society. He also founded Sensible BC — the largest grassroots cannabis reform organization in Canada. Additionally, Larsen worked as editor at Cannabis Culture Magazine for ten years, and is a co-founder of the Vancouver Seed Bank.

In a landmark court ruling out of British Columbia last month, Canadian medical marijuana patients won the right to homegrown cannabis. The ruling, issued by Federal Judge Michael Phelan, found that Health Canada’s current framework for a medical marijuana industry is unconstitutional and that Canadian patients’ right to grow their own medicine should be restored.

According to his new website, OvergrowCanada.com, Larsen has one million high-CBD cannabis seeds and 100,000 high-THC cannabis seeds that he is willing to give away. The seeds will be delivered in packages of 10 or 100 to Canadian patients who sign up via the website.

“Grow them on your balcony or your windowsill, grow them in your front yard or the back, but let us finally bring our plants out of the closet and into the fresh air where they belong,” Larsen wrote in his impassioned call for action.

“It doesn’t matter if you plan on using the buds. It doesn’t matter if the plants are female or male. It doesn’t matter if they grow 10 feet tall, or just 10 inches. ‎ All that matters is that Canadians join together, to plant these seeds and claim our right to grow….”

End


Review: Lyons Carry Cases

Lyons Carry Cases is a Seattle-based company dedicated to providing locally-manufactured, high quality pouches designed specifically for your pipe, pot, and vaporizer — and any other bit of paraphernalia that might be kicking around your pockets.

The fabric seems sturdy, and each Lyons case is clearly built to survive the regular wear and tear of everyday use.

lyons1
A medium-sized Lyons Carry Case. Large-sized case is pictured above.

Each pouch is designed to be opened and closed with ease using magnetic strips, so there’s no fuss messing with unnecessary zippers or buttons, and there is even gel padding worked into the pouch’s structure to help ensure the safety of your pipe, vaporizer, and any other fragile possessions.

It’s a neat niche product, but one that could also easily be used for carrying other important parts of your life, such as your cell phone, keys, or cash.

Currently, the Lyons Carry Case is offered in three sizes: small, medium and large. Visit the company website — www.lyons.land — to read more about their unique pipe pouch offerings, or to purchase your own!

End


National Poll: Americans Want Cannabis Rescheduled and Legalized

Yet another poll is suggesting what most people already know: U.S. citizens are ready to end the prohibition of marijuana.

Washington D.C. consulting firm Morning Consult released poll results last week that indicate 52 percent of registered American voters support the full recreational legalization of cannabis. Only 43 percent said they were opposed, and 5 percent were unsure.

The results come with a margin of error of +/- 2 percent.

83 percent of respondents agreed that cannabis has no place as a top priority controlled substance, believing that the plant should at the very least be rescheduled — or removed from the Controlled Substances Act entirely.

Unsurprisingly, cannabis reform was most popular among younger voters (63 percent of 18-29 year olds and 60 percent of 30-45 year olds) and Democrats (61 percent). Meanwhile, Republicans (37 percent) and older individuals (35 percent of voters aged 65 and higher) were the most likely to oppose the legalization of marijuana.

This poll echoes the same sentiments of nearly every recent national poll that has broached the subject, and is a clear sign that cannabis reform has gone mainstream in the past several years. With multiple legalization efforts underway for this coming election season, the U.S. appears poised to soon move beyond the tipping point of full-on federal reform.

End